{
  "$schema": "folio-library-entry/v1",
  "id": "9789241549912-webannexes-eng",
  "blocks": [
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 1",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../sections/page-001.md",
      "narrative": null,
      "content": "WHO recommendations \non antenatal care for a positive pregnancy experience: \nweb annexes*\n* The full guideline document is available at: http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/anc-positive-pregnancy-experience/en/",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Cover page for 'WHO recommendations on antenatal care for a positive pregnancy experience: web annexes', providing the title and the WHO Reproductive Health web link to the main guideline document.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 2",
      "pageStart": 2,
      "pageEnd": 2,
      "target": "../sections/page-002.md",
      "narrative": null,
      "content": "WHO Library Cataloguing-in-Publication Data\nWHO recommendations on antenatal care for a positive pregnancy experience.\nI.World Health Organization.\nISBN 978 92 4 154991 2\nSubject headings are available from WHO institutional repository\n© World Health Organization 2016\nAll rights reserved. Publications of the World Health Organization are available on the WHO website (http://www.who.int) or can be purchased from WHO Press, \nWorld Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: bookorders@who.int). \nRequests for permission to",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Imprint and copyright page (© World Health Organization 2016, ISBN 978-92-4-154991-2) for the Web Annexes of the 2016 WHO antenatal care guideline, including WHO Library Cataloguing-in-Publication data, WHO Press ordering and licensing information, and standard legal and liability disclaimers.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 3",
      "pageStart": 3,
      "pageEnd": 3,
      "target": "../sections/page-003.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\ni\nContents\nWeb annex 1: \t\nPriority questions and outcomes for the antenatal care (ANC) interventions identified for this guideline...............1\nWeb annex 2:\t\nChanges from the approved scope of this guideline................................................................................................................8\nWeb annex 3: \t\nGuideline Development Group (GDG) judgements related to the recommendations.................................................10\nEditing, design and layout: Green Ink, United K",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Table of contents (page i) for the Web Annexes of the 2016 WHO antenatal care guideline, listing Web annex 1 (Priority questions and outcomes for the ANC interventions identified for this guideline, p. 1), Web annex 2 (Changes from the approved scope of this guideline, p. 8), and Web annex 3 (Guideline Development Group judgements related to the recommendations, p. 10), with design and layout credit to Green Ink.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 4",
      "pageStart": 4,
      "pageEnd": 4,
      "target": "../sections/page-004.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n1\nWeb annex 1: \t Priority questions and outcomes for the antenatal care (ANC) \ninterventions identified for this guideline\nP=Population; I=Intervention; C=Comparator; O=Outcomes\nKey questions\nPriority outcomes\nA. Nutritional interventions\n1.\t Dietary interventions\nA.1.1:\tFor pregnant women (P), do diet and/or exercise interventions (I) compared with standard \nANC (C) improve maternal and perinatal outcomes (O)?\nA.1.2: For pregnant women in undernourished populations (P), does energy and protein dietary \neduc",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "First page of Web annex 1 (document page 1), tabulating the PICO (Population, Intervention, Comparator, Outcomes) priority questions and maternal/perinatal outcomes for Section A (Nutritional interventions), covering 1. Dietary interventions (A.1.1 diet/exercise, A.1.2 energy/protein education, A.1.3 balanced energy/protein supplements, A.1.4 high-protein supplementation), 2. Iron and folic acid supplements (A.2.1 daily, A.2.2 intermittent), 3. Calcium supplements (A.3), and 4. Vitamin A supplements (A.4).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 5",
      "pageStart": 5,
      "pageEnd": 5,
      "target": "../sections/page-005.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n2\nKey questions\nPriority outcomes\n5.\t Zinc supplements\nA.5: For pregnant women (P), does zinc supplementation (I) compared with no intervention or \nplacebo (C) improve maternal and perinatal outcomes (O)?\n•\t Maternal morbidity (infections)\n•\t Mode of delivery\n•\t Maternal satisfaction \n•\t Side-effects \n•\t Fetal/newborn morbidity (congenital anomaly, SGA, low birth weight, preterm \nbirth)\n•\t Fetal/newborn mortality\n6.\t Multiple micronutrient supplments\nA.6: For pregnant women (P), do micronutrient supplements",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Second page of Web annex 1 (document page 2), continuing the PICO key questions and priority maternal and fetal/newborn outcomes for Section A (Nutritional interventions): 5. Zinc supplements (A.5), 6. Multiple micronutrient supplements (A.6), 7. Vitamin B6 (pyridoxine) supplements (A.7), 8. Vitamin E and C supplements (A.8), 9. Vitamin D supplements (A.9), and 10. Restricting caffeine intake (A.10).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 6",
      "pageStart": 6,
      "pageEnd": 6,
      "target": "../sections/page-006.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n3\nKey questions\nPriority outcomes\nB. Maternal and fetal assessment\nB.1. Maternal assessment\n1.\t Anaemia\nB.1.1: For pregnant women (P), what is the diagnostic value of on-site tests for assessing blood \nhaemoglobin concentration (I) compared with the reference standard (full blood count) (C) to detect \nmaternal anaemia (O)?\n•\t Sensitivity and specificity in detecting anaemia (< 11 g/dL or < 10 g/dl) and severe \nanaemia (< 6 g/dL)\n2.\t Asymptomatic bacteriuria (ASB)\nB.1.2: For pregnant women (P), what is the di",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Third page of Web annex 1 (document page 3), listing PICO key questions and priority outcomes for Section B.1 (Maternal assessment): 1. Anaemia on-site haemoglobin tests vs full blood count (B.1.1), 2. Asymptomatic bacteriuria Gram stain and dipstick tests vs urine culture (B.1.2), 3. Routine clinical enquiry for intimate partner violence (B.1.3), and four integrated WHO guideline questions covering 4. Gestational diabetes mellitus diagnostic criteria (B.1.4), 5. Tobacco use screening (B.1.5), 6. Alcohol and substance abuse screening (B.1.6), and 7. HIV and syphilis screening (B.1.7), with footnotes citing the source 2013–2015 WHO guidelines.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 7",
      "pageStart": 7,
      "pageEnd": 7,
      "target": "../sections/page-007.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n4\nKey questions\nPriority outcomes\n8.\t Tuberculosis (TB)\nB.1.8: For pregnant women (P), does screening women for TB infection in ANC settings (I) compared \nwith not screening for TB (C) improve health outcomes (O)?\n•\t Refer to the relevant WHO guideline for the priority outcomes that informed this \nrecommendation5\nB.2. Fetal assessment\n1.\t Daily fetal movement counting\nB.2.1: For pregnant women (P), does daily fetal movement counting (I) compared with standard ANC \n(C) improve maternal and perinatal outcomes",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Fourth page of Web annex 1 (document page 4), listing PICO key questions and priority outcomes for maternal tuberculosis screening (B.1.8, integrated from the 2013 WHO TB screening guideline), all five Section B.2 (Fetal assessment) interventions—1. Daily fetal movement counting (B.2.1), 2. Symphysis-fundal height measurement vs clinical palpation (B.2.2), 3. Routine antenatal cardiotocography (B.2.3), 4. Routine early or late fetal ultrasound scan (B.2.4), and 5. Routine Doppler ultrasound of fetal blood vessels (B.2.5)—and the first two Section C (Preventive measures) interventions: 1. Antibiotics for asymptomatic bacteriuria (C.1) and 2. Antibiotic prophylaxis for recurrent UTIs (C.2).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 8",
      "pageStart": 8,
      "pageEnd": 8,
      "target": "../sections/page-008.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n5\nKey questions\nPriority outcomes\n3.\t Antenatal anti-D immunoglobulin administration\nC.3: For non-sensitized RhD-negative pregnant women (P), is routine prophylactic antenatal anti-D \nadministration (I) compared with no anti-D (C) effective for preventing Rhesus alloimmunization (O) \nand improving outcomes?\n•\t Maternal alloimmunization\n•\t Fetal/newborn morbidity (haemolytic disease of the newborn)\n•\t Fetal/newborn mortality\n4.\t Preventive anthelminthic treatment\nC.4: For pregnant women (P), does prophylactic",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Fifth page of Web annex 1 (document page 5), listing PICO key questions and priority outcomes for the remaining Section C (Preventive measures) interventions—3. Antenatal anti-D immunoglobulin administration (C.3), 4. Preventive anthelminthic treatment (C.4), 5. Tetanus toxoid vaccination (C.5), 6. Malaria intermittent preventive treatment in pregnancy (C.6, integrated from the 2015 WHO malaria treatment guidelines), and 7. Pre-exposure prophylaxis (PrEP) for HIV prevention (C.7, integrated from the 2015 WHO ART/PrEP guideline)—plus the first three Section D (Interventions for common physiological symptoms) questions: 1. Nausea and vomiting (D.1), 2. Heartburn (D.2), and 3. Leg cramps (D.3).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 9",
      "pageStart": 9,
      "pageEnd": 9,
      "target": "../sections/page-009.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n6\nKey questions\nPriority outcomes\n4.\t Low back and pelvic pain\nD.4: For pregnant women (P), what interventions (pharmacological or non-pharmacological) for \npelvic and back pain (I) compared with no interventions (C) reduce morbidity and improve outcomes \n(O)? \n•\t Symptomatic relief from pelvic and back pain \n•\t Side-effects \n•\t Maternal satisfaction and/or women’s rating of usefulness of treatment\n5.\t Constipation\nD.5: For pregnant women (P), what interventions (pharmacological or non-pharmacological) for",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sixth page of Web annex 1 (document page 6), listing PICO key questions and priority outcomes for the remaining Section D physiological symptom interventions—4. Low back and pelvic pain (D.4), 5. Constipation (D.5), and 6. Varicose veins and oedema (D.6)—and the first five Section E (Health system interventions to improve the utilization and quality of ANC) questions: 1. Woman-held case notes (E.1), 2. Midwife-led continuity of care (E.2), 3. Group antenatal care (E.3), 4. Community-based interventions to improve communication and support (E.4), and 5. Task shifting components of ANC delivery (E.5, referencing the 2012 WHO OptimizeMNH guideline).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 10",
      "pageStart": 10,
      "pageEnd": 10,
      "target": "../sections/page-010.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n7\nKey questions\nPriority outcomes\n6.\t Recruitment and retention of staff in rural and remote areas\nE.6: Should education, regulatory, financial and supportive interventions be used to improve \nrecruitment and retention of health workers in remote and rural areas?\n•\t Coverage of key ANC interventions\n•\t Refer to the relevant WHO guideline for the priority outcomes that informed this \nrecommendation9\n7.\t ANC contact schedules\nE.7: Should alternative models of ANC with four visits (FANC) be recommended instead",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Seventh and final page of Web annex 1 (document page 7), listing PICO key questions and priority outcomes for the concluding Section E health system interventions: 6. Recruitment and retention of staff in rural and remote areas (E.6, referencing the 2010 WHO rural retention guideline) and 7. ANC contact schedules comparing 4-visit FANC with 8-visit standard care (E.7).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 11",
      "pageStart": 11,
      "pageEnd": 11,
      "target": "../sections/page-011.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n8\nWeb annex 2:\t Changes from the approved scope of this guideline\nP=Population; I=Intervention; C=Comparator; O=Outcomes \nPICO questions omitted after the ANC guideline proposal \nwas approved\nReason\nConsideration of potential bias \nFor pregnant women (P), which strategies for screening gestational \ndiabetes mellitus (GDM) and subsequent management (I) compared with \nalternative strategies (C) reduce morbidity and improve outcomes (O)? \nSeveral potentially relevant Cochrane reviews on GDM \nscreening and preve",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "First page of Web annex 2 (document page 8, 'Changes from the approved scope of this guideline'), tabulating PICO questions omitted after approval of the ANC guideline proposal, the reasons for omission, and considerations of potential bias. Covers omitted questions on gestational diabetes mellitus (GDM) screening/management and prognostic tests (deferred to a dedicated WHO GDM guideline), home uterine monitoring and vibroacoustic stimulation (excluded as high-risk pregnancy interventions), syphilis diagnostic and prognostic strategies (deferred to a dedicated WHO syphilis screening guideline), and lower genital tract infection screening, prognostic tests, and prophylactic antibiotics (deferred for synthesis within the next five years).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 12",
      "pageStart": 12,
      "pageEnd": 12,
      "target": "../sections/page-012.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n9\nPICO questions omitted after the ANC guideline proposal \nwas approved\nReason\nConsideration of potential bias \nFor pregnant women (P), does vaccination against haemophilus influenza \ntype B (I) compared with no vaccination (C) reduce morbidity and improve \noutcomes (O)?\nThe WHO Steering Group decided that these questions \nrequire in-depth consideration as part of a specific WHO \nguideline on vaccinations in pregnancy, and could not be \nattempted within the time-frame of the ANC guideline.\nOmitting these que",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Second and final page of Web annex 2 (document page 9), completing the table of PICO questions omitted after guideline scope approval along with reasons and bias assessments: maternal vaccination against Haemophilus influenzae type B and viral influenza (deferred to a specific WHO guideline on vaccinations in pregnancy), interventions to prevent domestic violence/intimate partner violence (excluded as targeting a high-risk subpopulation outside routine ANC scope), and maternal iodine supplementation (deferred pending completion of a dedicated WHO iodine supplementation guideline).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 13",
      "pageStart": 13,
      "pageEnd": 13,
      "target": "../sections/page-013.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n10\nWeb annex 3: \t Guideline Development Group (GDG) judgements related to the \nrecommendations\nRecommendation \nA.1.1\nA.1.2\nA.1.3\nIntervention\nHealthy eating and \nphysical activity\nEducation on increasing energy \nand protein intake\nBalanced energy and \nprotein supplements\nCertainty of the \nevidence\n\t High (EGWG)\n\t Moderate (macrosomia, neonatal respiratory \nmorbidity)\n\t Low\n\t Very low\n\t High\n\t Moderate\n\t Low (LBW)\n\t Very low\n\t High\n\t Moderate (SGA, stillbirths)\n\t Low\n\t Very low\nEffects\n\t Favours this option",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "First page of Web annex 3 (document page 10, 'Guideline Development Group (GDG) judgements related to the recommendations'), presenting the Evidence-to-Decision (EtD) judgement grid across nine rows (Certainty of the evidence, Effects, Women's values, Resource use, Equity, Acceptability, Feasibility, Balance of benefits versus disadvantages, and GDG decision) for dietary interventions A.1.1 (healthy eating and physical activity; high certainty for EGWG, moderate for macrosomia and neonatal respiratory morbidity; Recommended), A.1.2 (education on increasing energy and protein intake; low certainty for LBW; Context-specific recommendation), and A.1.3 (balanced energy and protein supplements; moderate certainty for SGA and stillbirths; Context-specific recommendation).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 14",
      "pageStart": 14,
      "pageEnd": 14,
      "target": "../sections/page-014.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n11\nRecommendation \nA.1.4\nA.2.1\nA.2.2\nIntervention\nHigh-protein supplements\nDaily oral iron and \nfolic acid supplements\nIntermittent oral iron and \nfolic acid supplements\nCertainty of the \nevidence\n\t High (SGA)\n\t Moderate\n\t Low\n\t Very low\n\t High (very PTB)\n\t Moderate (maternal infection)\n\t Low (anaemia, LBW, Hb)\n\t Very low\n\t High\n\t Moderate (nausea)\n\t Low (anaemia, LBW)\n\t Very low\nEffects\n\t Favours this option\n\t Neither favours this option nor other options\n\t Favours other options\n\t Favours this option\n\t Neit",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Second page of Web annex 3 (document page 11), presenting the GDG Evidence-to-Decision judgement grid across certainty of evidence, effects, women's values, resource use, equity, acceptability, feasibility, benefit–disadvantage balance, and GDG decision for Recommendations A.1.4 (high-protein supplements; high certainty for SGA harm; Not recommended), A.2.1 (daily oral iron and folic acid supplements; high certainty for very preterm birth, moderate for maternal infection, low for anaemia/LBW/Hb; Recommended), and A.2.2 (intermittent oral iron and folic acid supplements; moderate certainty for nausea, low for anaemia/LBW; Context-specific recommendation).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-015",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 15",
      "pageStart": 15,
      "pageEnd": 15,
      "target": "../sections/page-015.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n12\nRecommendation \nA.3\nA.4\nA.5\nIntervention\nCalcium supplements\nVitamin A supplements\nZinc supplements\nCertainty of the \nevidence\n\t High\n\t Moderate (PTB)\n\t Low\n\t Very low\n\t High\n\t Moderate (maternal anaemia)\n\t Low (maternal infection)\n\t Very low\n\t High\n\t Moderate\n\t Low (PTB)\n\t Very low \nEffects\n\t Favours this option\n\t Neither favours this option nor other options\n\t Favours other options\n\t Favours this option\n\t Neither favours this option nor other options\n\t Favours other options\n\t Favours this option\n\t Neith",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Third page of Web annex 3 (document page 12), presenting the GDG Evidence-to-Decision judgement grid for micronutrient Recommendations A.3 (calcium supplements; moderate certainty for preterm birth, disadvantages outweigh benefits for all women universally; Context-specific recommendation for low-calcium populations), A.4 (vitamin A supplements; moderate certainty for maternal anaemia, low for maternal infection; Context-specific recommendation where deficiency is a severe public health problem), and A.5 (zinc supplements; low certainty for preterm birth; Context-specific recommendation in rigorous research).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-016",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 16",
      "pageStart": 16,
      "pageEnd": 16,
      "target": "../sections/page-016.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n13\nRecommendation \nA.6\nA.7\nA.8\nIntervention\nMMN supplements\nVitamin B6 supplements\nVitamin E and C supplements\nCertainty of the \nevidence\n\t High (LBW)\n\t Moderate\n\t Low\n\t Very low\n\t High\n\t Moderate\n\t Low\n\t Very low\n\t High (PROM, abdominal pain)\n\t Moderate (placental abruption)\n\t Low\n\t Very low\nEffects\n\t Favours this option\n\t Neither favours this option nor other options\n\t Favours other options\n\t Favours this option\n\t Neither favours this option nor other options\n\t Favours other options\n\t Favours this option",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Fourth page of Web annex 3 (document page 13), presenting the GDG Evidence-to-Decision judgement grid across certainty of evidence, EtD domains, benefit–disadvantage balance, and GDG decision for Recommendations A.6 (multiple micronutrient [MMN] supplements; high certainty for LBW reduction but resource/mortality concerns; Not recommended), A.7 (vitamin B6 supplements; Not recommended), and A.8 (combined vitamin E and C supplements; high certainty for PROM and abdominal pain, moderate for placental abruption; Not recommended).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-017",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 17",
      "pageStart": 17,
      "pageEnd": 17,
      "target": "../sections/page-017.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n14\nRecommendation \nA.9\nA.10\nB.1.1\nIntervention\nVitamin D supplements\nRestricting caffeine intake\nDiagnosing anaemia (haemoglobinometer \nvs Hb colour scale)\nCertainty of the \nevidence\n\t High\n\t Moderate (pre-eclampsia, PTB)\n\t Low\n\t Very low\n\t High\n\t Moderate (LBW, pregnancy loss)\n\t Low\n\t Very low\n\t High\n\t Moderate (haemoglobinometer has better \nsensitivity and specificity)\n\t Low\n\t Very low\nEffects\n\t Favours this option\n\t Neither favours this option nor other options\n\t Favours other options\n\t Favours this optio",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Fifth page of Web annex 3 (document page 14), presenting the GDG Evidence-to-Decision judgement grid for Recommendations A.9 (vitamin D supplements; moderate certainty for pre-eclampsia and preterm birth; Not recommended), A.10 (restricting caffeine intake; moderate certainty for LBW and pregnancy loss; Context-specific recommendation for women with high daily intake >300 mg), and B.1.1 (diagnosing anaemia with on-site haemoglobinometer vs haemoglobin colour scale; moderate certainty that haemoglobinometer has superior sensitivity and specificity; Context-specific recommendation).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-018",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 18",
      "pageStart": 18,
      "pageEnd": 18,
      "target": "../sections/page-018.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n15\nRecommendation \nB.1.2\nB.1.3\nB.2.1\nIntervention\nDiagnosing ASB: \nGram stain versus dipstick\nIntimate partner violence (IPV) \nclinical enquiry\nDaily fetal movement counting\nCertainty of the \nevidence\n\t High\n\t Moderate\n\t Low \n\t Very low (Gram stain has better sensitivity and \nspecificity)\n\t High\n\t Moderate\n\t Low (improves IPV detection)\n\t Very low\n\t High\n\t Moderate\n\t Low (no effect)\n\t Very low (no effect)\nEffects\n\t Favours this option\n\t Neither favours this option nor other options\n\t Favours other options",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sixth page of Web annex 3 (document page 15), presenting the GDG Evidence-to-Decision judgement grid for Recommendations B.1.2 (diagnosing asymptomatic bacteriuria with on-site Gram stain vs dipstick; very low certainty that Gram stain has better sensitivity and specificity; Context-specific recommendation), B.1.3 (intimate partner violence [IPV] clinical enquiry; low certainty that enquiry improves IPV detection; Context-specific recommendation when minimum support requirements are met), and B.2.1 (daily fetal movement counting; low to very low certainty of no effect; Context-specific recommendation in research).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-019",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 19",
      "pageStart": 19,
      "pageEnd": 19,
      "target": "../sections/page-019.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n16\nRecommendation \nB.2.2\nB.2.3\nB.2.4\nIntervention\nSymphysis-fundal height (SFH) measurement\nRoutine antenatal cardiotocography (CTG)\nEarly ultrasound scan\nCertainty of the \nevidence\n\t High\n\t Moderate\n\t Low\n\t Very low\n\t High\n\t Moderate\n\t Low\n\t Very low (no evidence)\n\t High\n\t Moderate\n\t Low (maternal satisfaction, congenital anomalies, \nIOL, multiple pregnancy)\n\t Very low\nEffects\n\t Favours this option\n\t Neither favours this option nor other options\n\t Favours other options\n\t Favours this option\n\t Neither favour",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Seventh page of Web annex 3 (document page 16), presenting the GDG Evidence-to-Decision judgement grid for fetal assessment Recommendations B.2.2 (symphysis-fundal height [SFH] measurement vs clinical palpation; Context-specific recommendation not to replace existing practice), B.2.3 (routine antenatal cardiotocography [CTG]; very low certainty/no evidence of benefit; Not recommended), and B.2.4 (early ultrasound scan before 24 weeks; low certainty for maternal satisfaction, congenital anomaly detection, induction of labour, and multiple pregnancy detection; Recommended).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-020",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 20",
      "pageStart": 20,
      "pageEnd": 20,
      "target": "../sections/page-020.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n17\nRecommendation \nB.2.5\nC.1\nC.2\nIntervention\nRoutine Doppler ultrasound \nof fetal blood vessels\nAntibiotics for ASB\nAntibiotic prophylaxis to prevent recurrent \nurinary tract infections\nCertainty of the \nevidence\n\t High\n\t Moderate\n\t Low (perinatal mortality)\n\t Very low\n\t High (short course on LBW and ASB persistence)\n\t Moderate\n\t Low\n\t Very low (pyelonephritis)\n\t High\n\t Moderate\n\t Low\n\t Very low\nEffects\n\t Favours this option\n\t Neither favours this option nor other options\n\t Favours other options\n\t Favours t",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Eighth page of Web annex 3 (document page 17), presenting the GDG Evidence-to-Decision judgement grid for Recommendations B.2.5 (routine Doppler ultrasound of fetal blood vessels; low certainty for perinatal mortality; Not recommended), C.1 (antibiotics for asymptomatic bacteriuria; high certainty for 7-day over short course on LBW and ASB persistence, very low for pyelonephritis; Recommended), and C.2 (antibiotic prophylaxis to prevent recurrent urinary tract infections; Context-specific recommendation in research).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-021",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 21",
      "pageStart": 21,
      "pageEnd": 21,
      "target": "../sections/page-021.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n18\nRecommendation \nC.3\nC.4\nC.5\nIntervention\nAntenatal anti-D immunoglobulin \nadministration\nProphylactic anthelminthic treatment \n(one dose)\nTetanus vaccination\nCertainty of the \nevidence\n\t High\n\t Moderate\n\t Low\n\t Very low\n\t High\n\t Moderate\n\t Low\n\t Very low\n\t High\n\t Moderate (neonatal mortality)\n\t Low (neonatal tetanus, side-effects)\n\t Very low\nEffects\n\t Favours this option\n\t Neither favours this option nor other options\n\t Favours other options\n\t Favours this option\n\t Neither favours this option nor other op",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Ninth page of Web annex 3 (document page 18), presenting the GDG Evidence-to-Decision judgement grid for preventive Recommendations C.3 (antenatal anti-D immunoglobulin administration in non-sensitized Rh-negative women; Context-specific recommendation in research), C.4 (single-dose prophylactic anthelminthic treatment after the first trimester; Context-specific recommendation in endemic areas), and C.5 (tetanus toxoid vaccination; moderate certainty for neonatal mortality, low for neonatal tetanus and side-effects; Recommended).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-022",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 22",
      "pageStart": 22,
      "pageEnd": 22,
      "target": "../sections/page-022.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n19\nRecommendation \nE.1\nE.2\nE.3\nIntervention\nWoman-held case notes\nMidwife-led continuity of care\nGroup ANC\nCertainty of the \nevidence\n\t High\n\t Moderate (maternal satisfaction)\n\t Low\n\t Very low\n\t High\n\t Moderate (vaginal birth, perinatal mortality, PTB)\n\t Low (caesarean section, maternal satisfaction)\n\t Very low\n\t High\n\t Moderate\n\t Low (PTB, maternal satisfaction)\n\t Very low\nEffects\n\t Favours this option\n\t Neither favours this option nor other options\n\t Favours other options\n\t Favours this option\n\t Neither fa",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Tenth page of Web annex 3 (document page 19), presenting the GDG Evidence-to-Decision judgement grid for health system Recommendations E.1 (woman-held case notes; moderate certainty for maternal satisfaction; Recommended), E.2 (midwife-led continuity of care [MLCC]; moderate certainty for vaginal birth, perinatal mortality, and preterm birth, low for caesarean section and maternal satisfaction; Context-specific recommendation in settings with well-functioning midwifery programmes), and E.3 (group ANC; low certainty for preterm birth and maternal satisfaction; Context-specific recommendation in research).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-023",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 23",
      "pageStart": 23,
      "pageEnd": 23,
      "target": "../sections/page-023.md",
      "narrative": null,
      "content": "WHO recommendations on antenatal care for a positive pregnancy experience: web annexes\n20\nRecommendation \nE.4.1\nE.4.2\nE.7\nIntervention\nParticipatory learning and action cycles \nwith women’s groups\nCommunity mobilization \nand ANC home visits\nFour-visit ANC model \nvs “standard” ANC models \nCertainty of the \nevidence\n\t High\n\t Moderate\n\t Low (maternal mortality, perinatal mortality)\n\t Very low\n\t High\n\t Moderate (perinatal mortality, ANC coverage 1+)\n\t Low\n\t Very low\n\t High\n\t Moderate (perinatal mortality)\n\t Low (maternal satisfaction)\n\t Very low\nEffects\n\t Favours this option\n\t Neither favours this",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Eleventh and final page of Web annex 3 (document page 20), presenting the GDG Evidence-to-Decision judgement grid for Recommendations E.4.1 (participatory learning and action [PLA] cycles with women's groups; low certainty for maternal and perinatal mortality; Context-specific recommendation), E.4.2 (community mobilization and ANC home visits; moderate certainty for perinatal mortality and ANC 1+ coverage; Context-specific recommendation), and E.7 (four-visit FANC model vs standard 8-visit ANC models; moderate certainty for increased perinatal mortality with 4 visits, low for maternal satisfaction, favouring 8 contacts; Recommended: minimum 8 contacts), along with an abbreviation key for Web annex 3.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    },
    {
      "id": "library/9789241549912-webannexes-eng/blocks/prose-page-024",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 24",
      "pageStart": 24,
      "pageEnd": 24,
      "target": "../sections/page-024.md",
      "narrative": null,
      "content": "For more information, please contact:\nDepartment of Reproductive Health and Research\nWorld Health Organization\n20 Avenue Appia, 1211 Geneva 27\nSwitzerland\nFax: +41 22 791 4171\nEmail: reproductivehealth@who.int\nWebsite: www.who.int/reproductivehealth\nDepartment of Maternal, Newborn, Child and Adolescent Health\nWorld Health Organization\n20 Avenue Appia, 1211 Geneva 27\nSwitzerland\nTel. +41 22 791 3281\nFax: +41 22 791 4853\nEmail: mncah@who.int\nWebsite: www.who.int/maternal_child_adolescent\nDepartment of Nutrition for Health and Development\nWorld Health Organization\n20 Avenue Appia, 1211 Geneva 27",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Back cover (page 24) of the Web Annexes for the 2016 WHO antenatal care guideline, providing postal addresses, fax/telephone numbers, email addresses, and websites for the WHO Department of Reproductive Health and Research, Department of Maternal, Newborn, Child and Adolescent Health, and Department of Nutrition for Health and Development in Geneva, plus ISBN 978-92-4-154991-2.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-10-28"
      }
    }
  ]
}
